ClinicalTrials.govpublic full text
Assess the Oral Bioavailability of New ABT-263 Formulations
chronic lymphocytic leukemia, lymphomas, leukemias, other hematological and non-hematological malignancies, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880350
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.